ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : nut allergens
Clear All
Filter by Field of Research
Anaesthesiology (7)
Medical and Health Sciences (4)
Respiratory Diseases (2)
Allergy (1)
Clinical chemistry (incl. diagnostics) (1)
Infectious Diseases (1)
Optical technology (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (32)
Filter by Status
Closed (32)
Filter by Scheme
NHMRC Project Grants (28)
NHMRC Research Fellowships (3)
NHMRC Postgraduate Scholarships (1)
Filter by Country
Australia (3)
Filter by Australian State/Territory
NSW (2)
VIC (1)
  • Researchers (0)
  • Funded Activities (32)
  • Organisations (0)
  • Funded Activity

    Immunological And Molecular Basis Of Anaphylaxis Caused By Peanut And Tree Nut Allergy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $195,691.00
    Summary
    An allergy to nuts is estimated to affect 1% of the population and peanuts are the major cause of fatal food-induced anaphylaxis. Five deaths occurred in the UK in 1993 which attracted media attention to the gravity of this problem. Proteins in the nut trigger a massive immunological reaction that causes the body to go into anaphylactic shock in which all the major body systems shut down. Nut allergy usually presents in infancy and persists indefinitely. As nuts are used in a wider and less visi .... An allergy to nuts is estimated to affect 1% of the population and peanuts are the major cause of fatal food-induced anaphylaxis. Five deaths occurred in the UK in 1993 which attracted media attention to the gravity of this problem. Proteins in the nut trigger a massive immunological reaction that causes the body to go into anaphylactic shock in which all the major body systems shut down. Nut allergy usually presents in infancy and persists indefinitely. As nuts are used in a wider and less visible range of food products, sensitisation is increasing and occurring earlier. It has been proposed, wrongly, that peanut (groundnut) allergic patients do not suffer from allergy to tree nuts (hazel, almond, Brazil, walnut). However a British survey of 1250 patients suffering from peanut anaphylaxis revealed that 50% of people with peanut allergy are also allergic to other nuts confirming our own clinical observations. At present, unlike insect venom allergy, grass pollen allergy and house dust mite allergy, there is no preventative treatment available. We plan to explore peanut allergy and investigate cross-reactivity between peanuts and major tree nuts to attempt to identify an allergen(s) that could explain the molecular nature of the allergy and offer approaches to immunotherapy. This information is necessary if we are to achieve safe and effective allergy shots for patients with this life long and life-threatening allergy as well as assisting in the development of better diagnostic
    Read more Read less
    More information
    Funded Activity

    Uncoupled Research Fellowship

    Funder
    National Health and Medical Research Council
    Funding Amount
    $782,250.00
    More information
    Funded Activity

    Uncoupled Research Fellowship

    Funder
    National Health and Medical Research Council
    Funding Amount
    $658,750.00
    More information
    Funded Activity

    Role Of Allergens, Proteases And Protease Receptors In The Regulation Of Respiratory Epithelial Cell Function

    Funder
    National Health and Medical Research Council
    Funding Amount
    $345,898.00
    More information
    Funded Activity

    Antigens, Allergens And Immune Responses To Normal And Crusted Scabies

    Funder
    National Health and Medical Research Council
    Funding Amount
    $173,500.00
    More information
    Funded Activity

    Epitopes Of A Major Latex Allergen And Mutagenesis To Express Hypoallergenic Variants For Immunotherapy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $192,473.00
    More information
    Funded Activity

    Does The Chemical Activity Of An Allergen Promote Asthm A

    Funder
    National Health and Medical Research Council
    Funding Amount
    $429,127.00
    More information
    Funded Activity

    Measuring And Reducing The Mite Allergen Exposure Impor Tant For Asthma

    Funder
    National Health and Medical Research Council
    Funding Amount
    $157,192.00
    More information
    Funded Activity

    Characterisation Of The Human Cellular And Humoral Response To The Major Latex Allergen, HEV B 5.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $79,977.00
    More information
    Funded Activity

    Alternaria Exposure And Asthma Severity

    Funder
    National Health and Medical Research Council
    Funding Amount
    $252,806.00
    More information

    Showing 1-10 of 32 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback